Haodong Li

Haodong Li

Auto-generated profile, based on publicly available information

Haodong Li

College of Life Science, Shanxi Agricultural University

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 December 2025 in Science Advances
Verified
Journal Article
Open access
HLHaodong Li
Haodong Li
JBJie Bai
Jie Bai
XMXiaxian Ma
Xiaxian Ma
LLLinwei Li
Linwei Li
YLYuanchao Liu
Yuanchao Liu
CLChwee Teck Lim
Chwee Teck Lim
Cell sorting, essential for diagnostics and early intervention, has evolved from conventional methods to sophisticated microfluidic approaches. These miniaturized systems leverage precise hydrodynamic control, facilitating major advances in tumor cell isolation, single-cell analysis, and biomarker detection. However, the vast imaging data generated by these microfluidic techniques necessitate advanced computational methods. Machine learning, particularly computer vision and deep learning, now offers transformative capabilities for automated feature extraction, pattern recognition, and real-time classification, enhancing sorting accuracy, accelerating diagnostics, and informing clinical decisions. This review synthesizes the convergence of microfluidics and machine intelligence, examining their synergistic roles in flow-field optimization, cellular classification, and error correction. While highlighting breakthroughs in diagnostic sensitivity and analytical throughput, we critically address challenges including model generalizability and hardware-software integration. Last, we provide an outlook on multimodal data fusion and the development of on-chip intelligent systems, proposing a roadmap for advancing precision medicine through embedded, adaptive biosensing platforms.

4 August 2026 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
xiaoyan liuxiaoyan liu
xiaoyan liu
YLYuanchao Liu
Yuanchao Liu
JLJunwei Li
Junwei Li
ZWZhibei Wang
Zhibei Wang
MNMui Hoon Brenda Nai
Mui Hoon Brenda Nai
CLChwee Teck Lim
Chwee Teck Lim
The deformability of cancer cells is a critical indicator of their malignancy, as this mechanical property of cancer cells can reflect various biostructural and biochemical changes such as the cytoskeletons and protein expressions. However, selectively isolating and analyzing cell subpopulations with differing deformability and their associated biological properties remains challenging, especially at high throughput. Here, we introduce a microstructure-assisted spiral microfluidic platform that sorts cancer cells based on their deformability at ultrahigh throughput (>2,000,000 cells min −1 ) and couples the workflow to real-time, image-based phenotyping of cell parameters. We profile the sorted fractions and investigate a tripartite correlation between the deformability of cancer cells, the expression of proteins in different subpopulations, and the metastatic ability of cancer cells. This tripartite correlation has been confirmed in human breast cancer cell lines with metastatic potential (including MDA-MB-231 cells and BT-549 cells), where these cells are classified into subpopulations based on their deformability. The more deformable subpopulation exhibits increased invasiveness and distinct cytoskeletal remodeling and epithelial-to-mesenchymal transition (EMT)-associated protein signatures. Leveraging these deformability differences, our label-free platform enables high-throughput enrichment of aggressive cancer subpopulations and provides a scalable front end for liquid biopsy workflows. More broadly, deformability-based sorting may support improved analysis of rare metastasis-prone cells and accelerate high-throughput screening for mechano-targeted therapeutic strategies, offering a practical route to integrate cell deformability into precision oncology and therapy.